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Abstract
Hepatitis C is an infectious disease, caused by blood borne pathogen; the Hepatitis C Virus. In this study we
analyzed blood samples collected from various risk groups for the prevalence of anti-HCV and active HCV infection
with the help of Immunochromtographic tests and nested PCR. The prevalence of active HCV infection among the
high risk groups was 15.57% (26/167). The prevalence of HCV in individual risk groups was 15%, 28%, 8%, 14.28%
and 14.28% in the case of thalassemics, dialysis, major surgery group, dental surgery group and injection drug
users respectively. Our analysis reveals the fact that health care facilities in the Khyber Pakhtunkhwa province of
Pakistan are contributing a great deal towards the spread of HCV infection.
Introduction
Hepatitis C is an infectious disease affecting the liver,
caused by the hepatitis C virus (HCV). HCV, a member of
the Flaviviridae family, was discovered as a new viral
agent causing non-A, non-B hepatitis by Choo and co-
workers in 1989 [1]. WHO estimated the global prevalence
of Hepatitis C as 3% [2]. In developing countries where
resources and facilities may be significantly limited, the
prevalence of HCV is higher as compared to the developed
world [3].
HCV is transmitted through contaminated blood trans-
f u s i o n ,s u r g e r y ,s u r g i c a li n s t ruments, dental surgery and
excessive dental consultations, sexual contacts, drug
abuses, sharing of the house hold items such as razors,
toothbrushes and shaving from the barber [4-6]. Some
health care procedures, i.e., surgical and dental treatments,
have recently been indicated as risk factors for acute HCV
[7]. In Pakistan, blood transfusion is still a major source of
HCV transmission. Possible reasons for this include lack
of resources, weak infrastructure, ill-equipped resources,
poorly trained staff, inadequate policy implementation, fre-
quent power breakdown and ineffective screening of blood
donors for anti-HCV antibody [8]. Regular blood transfu-
sion in patients with hereditary hemolytic anemia,
particularly Thalassemia, has improved their overall survi-
val, but carries a definite risk of acquisition of blood-borne
virus infections, especially viral hepatitis [9].
Major risk factors associated with the transmission of
HCV were never investigated at molecular level in Khy-
ber Pakhtunkhwa. In this study, we have analyzed
patients belonging to various risk groups for the preva-
lence of anti HCV and active HCV infection. The risk
groups included thalasemics, major surgery group, den-
tal surgery group, dialysis group and IDUs (Injection
drug users).
Methods and materials
Sampling
After having approved the study by the ethics commit-
tee of the Institute of Biotechnology and Genetic Engi-
neering, Peshawar, a total of 167 blood samples were
collected from patients belonging to various risk groups
including thalassemics, major surgery group, dental sur-
gery group, injection drug users and dialysis group. Each
individual duly signed a proforma containing informa-
tion about his/her previous exposure to a risk factor,
age, sex etc. 5 mL of blood sample was collected in
EDTA-tubes in each case and immediately transported
to IBGE for serum isolation. Sera were stored at -20 C
until used. All experiments were performed inn accor-
dance with the ethical standards of the Declaration of
Helsinki.
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Screening for HCV positive samples was carried out
with the help of Immunochromatographic tests. Strips
used were from accurate and Acon (Acon, USA) accord-
ing to the manufacturers instructions. Samples positive
by ICT were further processed for next step evaluation.
RNA Extraction and RT-PCR
HCV RNA was extracted from 100 μls e r u mb yu s i n g
Anagen RNA extraction kit (Purescript, USA) according
to the manufacturer’s instructions. Qualitative detection
of serum HCV RNA was performed by Reverse tran-
scription PCR as mentioned previously [10].
Gel electrophoresis
PCR products were analyzed on 2% agarose gel prepared
in 0.5% TBE buffer, stained with Ethedium bromide
(10 μ g/ml) as florescent dye. A 100-bp DNA ladder
(Gibco BRL) was used as DNA size marker. Gels were
photographed using Alpha quant (Alpha Innotech).
The data was analyzed with SPSS version 10.0 for win-
dows or Microsoft Excel. Frequencies of hepatitis C in
different risk groups were calculated in percentages.
Results
A total of 167 blood samples were screened including
thalassemic patients, dialysis patients, people having
major surgeries, people having undergone dental sur-
geries (minor and major) and injection drug users.
Initial screening was done for anti-HCV using ICT
strips from two different sources. Confirmation of active
HCV infection was carried out with the help of RT-PCR.
Out of 167 samples, 26 (15.57%) were HCV positive both
for anti-HCV and HCV RNA. Prevalence of active HCV
infection in individual risk groups was 15%, 28%, 8%,
14.28% and 14.28% in thalasemics, dialysis, major surgery
group, dental surgery group and injection drug users
respectively (Table 1).
Exposure to various HCV risk factors is preferentially
gender specific in our country mainly due to our social
set up. Exposure of females to some of the risk factors is
limited. Among the observed population, 104 (62.27%)
were male and 63 (37.72%) were female out of which
18 (17.30%) males and 8 (12.68%) females were positive
for anti-HCV as well as HCV RNA (Table 2). In terms of
age distribution, the subjects were grouped into three
categories Lowest prevalence (12.20%) was recorded in
the case of patients with age 15 years or below, while in
the case of older age group (50 years and above),
the highest HCV prevalence (22.22%) was recorded
(Figure 1).
Out of the total 167 samples from different risk
groups included in the study, 3.59% were positive in the
case of thalassemia, 4.19% in dialysis, 1.19% in major
surgery, 2.99% in dental surgery and 3.59% in injection
drug users. Highest prevalence was observed in dialysis
patients (Table 3). Major risk factors for HCV transmis-
sion in KPK turned out to be dialysis followed by Thala-
semia, Injection drug use and dental surgery.
Discussion
Thalassemia major patients are among the high risk
groups for HCV infection. Earlier studies from various
regions of Pakistan have reported high prevalence of
HCV (20.5%-60%) among thalasemics [11-14] In this
study The prevalence of anti-HCV or HCV RNA in
individual group was 15% while among the high risk
groups, it was 3.59% (Table 1, 3) which is lower as com-
pared to the previous estimates [15]. Majority of the stu-
dies undertaken in Pakistan have relied on anti-HCV
detection in thalasemics using ICT devices and active
infection was never investigated. The limitations of ICT
devices for the detection of anti-HCV have been docu-
mented earlier [16]. Our own observation also re-
enforces the same [Unpublished data]. In KPK, where
resources are extremely limited to screen anti-HCV,
contaminated blood transfusion seems to be the most
important factor contributing a great deal towards the
spread of HCV in Thalasemic patients.
Major surgery also contributes towards HCV trans-
mission. In Khyber Pakhtunkhwa province of Pakistan,
the public sector hospitals are not adequately equipped
for screening of blood and blood products and accord-
ing to our own observation proper sterilization proce-
dures are also not practiced due to various reasons
including burden of patients undergoing surgeries or
sometimes lack of awareness about the transmission of
HCV. Earlier studies reported the prevalence of HCV in
major surgery groups as, 6.92%, 16.6%, 11.66% and
Table 1 Prevalence of HCV in individual risk groups
S.No Major Risk groups
(N)
ICT positive PCR positive
1 Thalassemia (40) 6 (15%) 6 (15%)
2 Dialysis (25) 7 (28%) 7 (28%)
3 Major surgery (25) 2 (8%) 2 (8%)
4 Dental surgery (35) 5 (14.28%) 5 (14.28%)
5 IDUs (42) 6 (14.28%) 6 (14.28%)
Total 167 26 (15.56%) 26 (15.56%)
Table 2 Sex wise prevalence of active HCV infection
Sex Total
samples
Positive
cases
Negative
cases
Prevalence
(%)
Male 104 18 86 17.30%
Female 63 8 55 12.68%
Total 167 26 141 15.57%
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Page 2 of 411.26% [17-20]. In this study, 2/25 (8%) of the indivi-
duals with no history of HCV infection prior to major
surgery turned out to be positive for anti-HCV and
HCV RNA (Table 1). Though the prevalence of active
HCV infection among the major surgery group is less
than the previous reports, however it is still alarmingly
high as compared to other parts of the world.
Dental surgery is one of the major risk factors for HCV
transmission in Pakistan. Some studies have reported
that dental procedures were the major source of exposure
(39.7%) followed by injections (16.6%) and surgical proce-
dures (16.6%) [21]. Also the contaminated dentist equip-
ments were the source of HCV infection in 17.94%
people [22]. In this study the prevalence of anti-HCV and
active HCV infection in the individual dental surgery
group was 14.28%. Detection of anti-HCV antibodies and
HCV RNA in patients who have a recent history of dental
surgery (major/minor) with no HCV infection prior to
the surgery indicates that dental surgical and scaling
instruments are not properly sterilized in our hospitals
and clinics. Apart from the public sector hospitals, we
observed that due to poor economic condition, many
people consult dental quakes practicing in various parts
of the province. None of the quakes were informed about
the risk of HCV transmission as a result of contaminated
equipments and they also were not aware about the steri-
lization procedures.
Hemodialysis is considered to be one of the major risk
factors for HCV transmission. Some earlier studies
reported that the prevalence of HCV in hemodialysis
patients was 68% in Pakistan, 23.7% in Quetta and
24.7% in Lahore [23-25]). In India the prevalence of anti
HCV is recorded as high as 83% in hemodialysis
patients [26]. In this study the prevalence of anti-HCV
antibodies and HCV RNA to be the highest as it was
28% in the individual risk group and 4.19% among the
high risk groups (Table 3). The highest prevalence of
HCV in dialysis group indicates the limitations of the
screening procedures used in these units for the detec-
tion of anti-HCV.
It is evident from the previous studies conducted in
Pakistan that injection drug use is a predominanat mode
of HCV transmission [27,28]. 60% of the hepatitis C
transmission in the United States is attributed to injec-
tion drug use [29] and 52% in Tehran [30]. In this study,
prevalence of anti-HCV and HCV RNA among the IDUs
was 14.28% in the individual group of IDUs while it was
3.59% among the entire load of samples tested. None of
the IDUs had a previous history of blood transfusion or
surgeries but all of them did share needles in the past.
Although, awareness about needle sharing has increased
in recent times, yet the poorly educated IDUs of KPK did
not seem to be aware of the risk of needle sharing.
It is also noted in this study that the prevalence of HCV
was higher in males (17.30%) as compared to females
(12.68%) which is in conformity with another local study
[18]. Higher prevalence of HCV in males is probably due
to exposure to numerous risk factors. According to our
cultural environment, females are only negligibly exposed
to some of the risk factors e.g. tattooing, injection drug
use, barbers etc. Higher prevalence in males seems to be
associated with our cultural attributes.
Conclusion
Lack of proper blood screening facilities in Khyber
Pakhtunkhwa province and the lack of awareness about
the possible transmission routes of HCV are contribut-
ing a great deal towards the spread of the infection
among the population. Proper sterilization and screening
procedures must be made mandatory on public sector
health care units so as to avoid a far bigger threat of
more HCV infections in the near future. The policy
makers should formulate laws and ensure its implemen-
tation with respect to banning the unqualified dental
quakes working in various parts of the province.
Table 3 Prevalence of HCV among the high risk groups
Sex Total samples HCV positive Thalassemia Dialysis Major surgery Dental surgery IDUs
Male 104 18 5 Nil 2 6
Female 63 8 1 2 2 3 Nil
Total 167 26 06 07 02 05 06
15.56% 3.59% 4.19% 1.19% 2.99% 3.59%
Figure 1 Age wise distribution of all the patients belonging to
various risk groups. White bars represent total number of patients
in each age group, grey bars represent HCV positive patients and
filled circles show the percentage of HCV infected individuals.
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